Canakinumab treat-to target strategies increase complete response rate in CAPS. Issue 1 (December 2015) - Kuemmerle-Deschner, J; Hofer, F; Endres, T; Kortus-Goetze, B; Blank, N; Weißbarth-Riedel, E; Schuetz, C; Kallinich, T; Krause, K; Rietschel, C; Horneff, G; Benseler, SM